NewsRack: prashantiyengar/IP/drugs

US urged to take tougher line on Indian trade practices - TOI: Intl Business

Tue, 14 May 2013 18:30:00 GMT

"The United States should not sit idly by as the Indian government enacts regulations that harm American industry and jobs," Stephen Ezell, senior analyst at the Information Technology & Innovation Foundation (ITIF), said in a paper.

Top Indian generic drug makers look to US as patents end - Rediff: Business

Wed, 08 May 2013 18:30:00 GMT

They seek to profit from big-selling drugs going off-patent this year in the lucrative market.

US company to receive patent for premature ejaculation topical medication - New Kerala: India News

Sat, 04 May 2013 18:30:00 GMT

Washington, May 5 : Absorption Pharmaceuticals, the maker of the world's first FDA-approved topical medication for premature ejaculation, has announced that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of the drug, Promescent.

US Food and Drug Administration approves drug to cut cholesterol - ET: Pharma

Sat, 04 May 2013 18:30:00 GMT

Morgan Liscinsky, an FDA spokeswoman, said high levels of LDL cholesterol were a known risk factor for heart disease.

Venus signs deal with Korean pharma - New Kerala: India News

Wed, 01 May 2013 18:30:00 GMT

Chandigarh, May 2: Research based pharmaceutical company, Venus Remedies Limited, on Thursday announced signing of its deal with Korean pharma giant Goodwills Co.

EU debates biopiracy law to protect indigenous people - Guardian: Environment

Tue, 30 Apr 2013 18:30:00 GMT

Pharmaceutical firms would need to compensate indigenous people for using their knowhow in creating new medicines The European parliament is debating a draft biopiracy law requiring industry to compensate indigenous people if it makes commercial use of local knowledge such as plant-based medicines. Under the law – based on the international convention on access to biodiversity, the Nagoya protocol – the pharmaceuticals industry would need the written consent of local or indigenous people before exploring their region's genetic resources or making use of their traditional knowhow. Relevant authorities would have the power to sanction companies that fail to comply, protecting local interests from the predatory attitude of big European companies. German firm patents South African herb The draft report on access to genetic resources by Green MEP Sandrine Bélier cites as an example a German pharmaceutical company's dealings in South Africa. Pelargonium sidoides, a variety of ...

Speech by the President of India, Shri Pranab Mukherjee on the occasion of the Convocation 2013 of Sido Kanhu Murmu - Govt of india: PIB

Mon, 29 Apr 2013 18:30:00 GMT

Speech by the President of India, Shri Pranab Mukherjee on the occasion of the Convocation 2013 of Sido Kanhu Murmu

License for Manufacturing Generic Anti-Cancer Drugs - Govt of india: PIB

Mon, 29 Apr 2013 18:30:00 GMT

License for Manufacturing Generic Anti-Cancer Drugs

Drug donations are great, but should Big Pharma be calling the shots? - The Guardian -- World Latest

Judith Soal — Sun, 28 Apr 2013 18:30:00 GMT

Giving out free medicines allows pharmaceutical companies to decide which diseases are treated – and which aren't In the early 2000s, pharmaceutical companies were high on activists' hit lists, prompted by Big Pharma's ill-advised attempt to sue the South African government for patent infringement on HIV drugs; an attempt to deal with the country's epidemic by allowing cheaper, generic copies to be sold. Today, the discourse seems merrier. Charities and NGOs sit down with the same companies, discussing how best to confront public health challenges in the developing world. The talk is of partnerships and "win-wins". It isn't all idle chatter. Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signalled a more collaborative approach, with the likes of GlaxoSmithKline, Sanofi, Johnson and Johnson and Merck all performing well in the 2012 Access to Medicine index . But while talk of a new era of friendship is ...

Little support for pharma MNCs on patent issue - TOI: Intl Business

Fri, 26 Apr 2013 18:30:00 GMT

Multinational drug companies that are complaining against the Indian government and patent authorities using flexibilities under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property rights are finding little support in the international community.

Government's Stand on Generic Drugs - Govt of india: PIB

Mon, 22 Apr 2013 18:30:00 GMT

Government's Stand on Generic Drugs

Growth will be back on track by elections, says FM - Rediff: Business

Wed, 17 Apr 2013 18:30:00 GMT

US Chamber of Commerce attacks India over intellectual property rights.

Made-in-India generics have low prices, meet high quality standards - TOI: India

Mon, 15 Apr 2013 18:30:00 GMT

Made-in-India generics have low prices, meet high quality standards

Struggle for life saving drugs - Rediff: Columns

Mon, 15 Apr 2013 18:30:00 GMT

People die from diseases like AIDS, TB, etc because life saving essential medicines are either too expensive, or not available because they are not seen as financially viable.

COLUMN: Struggle for life saving drugs - Rediff: Business

Mon, 15 Apr 2013 18:30:00 GMT

People die from diseases like AIDS, TB, etc because life saving essential medicines are either too expensive, or not available because they are not seen as financially viable.

Pfizer reduces field staff base in India - Rediff: Business

Mon, 15 Apr 2013 18:30:00 GMT

Employees allege forcible layoffs; firm says ensuring it "best maximises performance and optimises resources"

Novartis has 219 patents in India - Rediff: Business

Sun, 14 Apr 2013 18:30:00 GMT

Data contradict Swiss drug major's claim that India does not respect IPR.

India refutes US criticism of its FDI, IPR laws - Rediff: Business

Fri, 12 Apr 2013 18:30:00 GMT

USTR has said India imposed several barriers in major services industries such as insurance, banking, audiovisual, accounting, legal, telecommunications, distribution services, postal and express delivery services.

HC issues notice to Glenmark on Merck's petition on Patent rights - New Kerala: India News

Fri, 12 Apr 2013 18:30:00 GMT

New Delhi, Apr 12 : The Delhi High Court today issued notices to Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme's appeal against the single judge order refusing to restrain the Indian firm from manufacturing and selling anti-diabetic drugs Zita and Zita-Met.

'India, EU showing political will to seal FTA' - Rediff: Business

Thu, 11 Apr 2013 18:30:00 GMT

India was apprehensive because EU was pushing for data exclusivity provisions that would have affected domestic pharma companies.

Should pharma MNCs be peeved? - Rediff: Columns

Thu, 11 Apr 2013 18:30:00 GMT

In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.

Should pharma MNCs be peeved? - Rediff: Business

Thu, 11 Apr 2013 18:30:00 GMT

In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.

US supreme court to decide if companies can patent human genes - The Guardian -- World Latest

Karen McVeigh — Wed, 10 Apr 2013 18:30:00 GMT

Utah biotech firm to argue its patents on breast and ovarian cancer genes are necessary to fund further research The US supreme court will hear oral arguments next week to decide whether companies can patent human genes, in a landmark case which could alter the course of US medical research and the battle against diseases such as breast and ovarian cancer. A coalition of scientists, cancer survivors, patients, breast cancer groups and professional medical associations, which has brought the case, will argue that genes are "products of nature", like organs of the body and should not be exploited for commercial gain. Such patents are illegal and violate the first amendment, they say. They are challenging patents on two genes linked to breast and ovarian cancer owned by Myriad Genetics, a biotechnology company, because they say the patents have stymied research and the free exchange of ideas. Myriad, based in Salt Lake City, Utah, will ask the court to uphold the patents, which it says is ...

Indian patent rulings may face legal heat internationally - ET: Policy

Wed, 10 Apr 2013 18:30:00 GMT

Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India

Drug patent row: HC to hear US co on Apr 12 - Rediff: Business

Tue, 09 Apr 2013 18:30:00 GMT

A bench of justices Sanjay Kishan Kaul and Indermeet Kaur took the plea of US pharma major on record and posted it for hearing before another bench on April 12.